The UK has been an innovation and regulatory leader in the cell and gene therapy field since the emergence as an exciting new therapeutic modality began to gain momentum over the past 15 years or more. The UK, through public and private sector investment continues to be a leading location for innovation in the field although competition is never far away. This event will see presentations on the current landscape of the Cell & Gene Therapy development in the UK followed by a panel discussion exploring what the UK needs to do in order to remain a leading player in the space.

Agenda:
17.30  Registration and networking
18.00  Welcome from One Nucleus
18.05  Overview of Cell & Gene Therapy in the UK
18.50  Panel Discussion: How Will the UK Remain a Location of Choice for Cell & Gene Therapy Investment?
19.35  Closing Remarks
19.40  Networking over drinks and canapes
21.00  Close

Prices:
Members: Free
Non-members: £50 +VAT
Academics: please contact info@onenucleus.com